The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Cancer Imaging and Image-directed Interventions
Volume 14 - 2024 |
doi: 10.3389/fonc.2024.1439229
Prediction of HIF-1α Expression in Endometrial Carcinoma by enhanced T2 * weighted angiography and dynamic contrast-enhanced magnetic resonance imaging
Provisionally accepted- 1 Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei Province, China
- 2 Department of Radiology, the First Affiliated Hospital of Dalian Medical University,, Dalian, China
- 3 Philips (China), Beijing, Beijing Municipality, China
- 4 Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning Province, China
To explore the value of quantitative imaging parameters by enhanced T2 * weighted angiography (ESWAN) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for evaluating the expression of Hypoxia-inducible factor-1α (HIF-1α) in endometrial carcinoma (EC).: Data from 122 patients with EC confirmed by clinical pathology were retrospectively analyzed. According to the number of positive cells stained with HIF-1α by immunohistochemistry, patients were divided into two groups: 65 cases with high expression of HIF-1α and 57 cases with low expression of HIF-1α. All patients underwent preoperative 1.5T MRI scans, including ESWAN and DCE-MRI. The amplitude, phase, and R2 * values derived from ESWAN and the volume transfer constant (K trans ), rate constant (Kep), and extravascular volume fraction (Ve) values derived from DCE-MRI were measured by two observers,respectively. The intra-class correlation coefficient (ICC) was used to assess the measurement of reproducibility across observers, and the differences in imaging parameters between the two groups were compared using the independent sample t-test or Mann-Whitney U-test. Binary logistic regression analysis was used to find independent risk factors for HIF-1α expression. The efficacy of selected imaging parameters for predicting HIF-1α expression was assessed using receiver operating characteristic (ROC) curves, and the Delong test was used to compare the area under ROC curves (AUC).The consistency between the two observers was good (ICC>0.75). The R2 * , K trans , and Kep values of the HIF-1α high expression group were higher than those of the HIF-1α low expression group . Binary logistic regression analysis revealed that R2 * and Kep values were independent risk factors for HIF-1α expression. The AUC values of R2 * , Kep, and their combination for prediction of HIF-1α expression were 0.697, 0.677, and 0.781, respectively. The diagnostic efficacy was significantly improved with combination of R2 * and Kep. Conclusions: Quantitative parameters by ESWAN and DCE-MRI showed significant differences between EC patients with low and high expression of HIF-1α, and the combination of ESWAN and DCE-MRI improves the efficacy in prediction of HIF-1α expression in EC, which has an excellent clinical application prospect.
Keywords: endometrial carcinoma, Hypoxia-inducible factor-1α, Enhanced T2 * weighted angiography, dynamic contrast-enhanced, Magnetic Resonance Imaging
Received: 27 Jun 2024; Accepted: 07 Nov 2024.
Copyright: © 2024 Xie, Lin, Ma and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ai Lian Liu, Department of Radiology, the First Affiliated Hospital of Dalian Medical University,, Dalian, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.